Isotretinoin
Back to searchMolecule Structure
Scientific Name
Isotretinoin
Description of the Drug
Isotretinoin is a retinoid used to treat severe recalcitrant acne.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00982
http://www.drugbank.ca/drugs/DB00982
Brand Name(s)
Absorica, Absorica ld, Accutane, Amnesteem, Claravis, Isotrex, Myorisan, Roaccutane, Sotret, Zenatane
Company Owner(s)
Hoffmann La Roche Inc, Amneal Pharmaceuticals Of Ny Llc, Sun Pharmaceutical Industries Inc, Douglas Pharmaceuticals America Ltd, Sun Pharmaceutical Industries Ltd, Upsher Smith Laboratories Llc, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Retinoic acid receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363069 |
Clinical Trial(s)
Unichem Links
| Atlas | 13-cis retinoic acid | ||||||
| SureChEMBL | SCHEMBL38299 | ||||||
| Human Metabolome Database | HMDB0006219 | ||||||
| DrugBank | DB00982 | ||||||
| PubChem: Thomson Pharma | 14751738 | ||||||
| PubChem | 5282379 | ||||||
| NMRShiftDB | 60021103 | ||||||
| LINCS | LSM-42855 | ||||||
| Nikkaji | J1.313.475H | J8.772F | |||||
| BindingDB | 50031459 | ||||||
| EPA CompTox Dashboard | DTXSID4023177 | ||||||
| LipidMaps | LMPR01090021 | ||||||
| DrugCentral | 1508 | ||||||
| Metabolights | MTBLC6067 | ||||||
| Brenda | 71524 | 10467 | |||||
| Guide to Pharmacology | 7600 | ||||||
| rxnorm | ZENATANE | MYORISAN | SOTRET | ABSORICA | CLARAVIS | AMNESTEEM | ISOTRETINOIN |
| PubChem: Drugs of the Future | 12013352 | ||||||
| ChEBI | 6067 | ||||||
| ZINC | ZINC000003792789 |
